| May 19, 2010 |
| RANBAXY INTRODUIT L’ATORVASTATINE – MÉDICAMENT RÉDUCTEUR DU CHOLESTÉROL – AU SYSTÈME DE SOINS DE SANTÉ CANADIEN |
| |
 |
| Jul 29, 2009 |
| RANBAXY GAINS APPROVAL
TO MARKET RANTM-ROPINIROLE TABLETS IN CANADA
|
| |
|
| Jul 21, 2009 |
| RANBAXY RECEIVES FINAL APPROVAL TO MANUFACTURE AND MARKET RANTM-SIMVASTATIN TABLETS IN CANADA |
| |
|
| Jul 20, 2009 |
| RANBAXY RECEIVES FINAL APPROVAL TO MANUFACTURE AND MARKET RANTM-AMLODIPINE TABLETS IN CANADA |
| |
|
| Nov 21, 2007 |
| RANBAXY LAUNCHES RANTM-TAMSULOSIN HYDROCHLORIDE CAPSULES IN CANADA |
| |
|
| Oct 22, 2007 |
| RANBAXY RECEIVES APPROVAL TO MARKET RANTM-LISINOPRIL IN CANADA |
| |
|
| Sep 13, 2007 |
| CANADIAN FEDERAL COURT FAVOURS RANBAXY - DISMISSES PFIZER'S APPLICATION ON ATORVASTATIN PATENT CA 2,220,455 |
| |
|
| May 21, 2007 |
| RANBAXY RECEIVES APPROVAL TO MARKET RANTM-PRAVASTATIN IN CANADA |
| |
|
| Apr 11, 2007 |
| RANBAXY RECEIVES APPROVAL TO MARKET CEFPROZIL TABLETS AND CEFPROZIL POWDER FOR ORAL SUSPENSION IN CANADA |
| |
|
| Feb 07, 2007 |
| RANBAXY ANNOUNCES GLOBAL ENTRY INTO BIOSIMILARS WITH ZENOTECH TARGETS EU MARKETS FIRST |
| |
|
For further information please contact:
Ramesh L. Adige
Whole-time Director- Corporate Affairs
and Global Corporate Communications
Ranbaxy Laboratories Ltd.
Plot 90, Sector 32, Gurgaon
Haryana 122001, India
Tel: +91-124-5135000
e-mail: ramesh.adige@ranbaxy.com
or
Raghu Kochar
Director-Corporate Communications
Ranbaxy Laboratories Ltd
Plot 90, Sector 32, Gurgaon
Haryana 122001, India
Tel: +91-124-5135141
Mobile: 9811617256
e-mail: raghu.kochar@ranbaxy.com
or
Krishnan Ramalingam
Manager- Corporate Communications
Ranbaxy Laboratories Ltd.
Plot 90, Sector 32, Gurgaon
Haryana 122001, India
Tel: +91-124-5135143
Mobile: 9810042540
e-mail: krishnan.ramalingam@ranbaxy.com
